About file location

As the EGA is co-managed by the EMBL-EBI and CRG, files could be located in the UK and/or Spain, as indicated by their respective flags.

Alternatively, files could be located in one of the international Federated EGA nodes, as indicated next to the node's flag.
Need Help?

ChIP-Seq (H3K27ac) assays for reference epigenomes generated by Centre for Epigenome Mapping Technologies at Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, as part of the International Human Epigenome Consortium.

ChIP-Seq (H3K27ac) assays for reference epigenomes generated by Centre for Epigenome Mapping Technologies at Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.

Request Access

DUO:0000012
version: 2021-02-23

research specific restrictions

This data use modifier indicates that use is limited to studies of a certain research type.

DUO:0000025
version: 2021-02-23

time limit on use

This data use modifier indicates that use is approved for a specific number of months.

DUO:0000026
version: 2021-02-23

user specific restriction

This data use modifier indicates that use is limited to use by approved users.

DUO:0000027
version: 2021-02-23

project specific restriction

This data use modifier indicates that use is limited to use within an approved project.

BC Cancer, part of the Provincial Health Services Authority - Data Access Policy

Access to this data is controlled. There are a number of steps that a researcher must take to obtain access to this data, including execution of a Data Access Agreement between the institutions. The process is overseen by the Technology Development Office; please contact our general email address TDOadmin@phsa.ca. Please only click the "request data" button on the EGA website after a Data Access Agreement is fully executed.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001000552 Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Quality Report
Located in
i
EGAF00000586050 bam 3.3 GB Report
EGAF00000586057 bam 6.0 GB Report
EGAF00000586064 bam 5.5 GB Report
EGAF00000586071 bam 5.3 GB Report
EGAF00000586078 bam 2.6 GB Report
EGAF00000586085 bam 4.6 GB Report
EGAF00000586092 bam 3.3 GB Report
EGAF00000586099 bam 4.5 GB Report
EGAF00000586106 bam 4.9 GB Report
EGAF00000586113 bam 3.8 GB Report
EGAF00000733023 bam 3.4 GB Report
EGAF00000733042 bam 3.3 GB Report
EGAF00000733055 bam 3.5 GB Report
EGAF00000733061 bam 4.0 GB Report
EGAF00000733070 bam 10.2 GB Report
EGAF00000835461 bam 3.9 GB Report
EGAF00000835471 bam 3.3 GB Report
EGAF00000835484 bam 4.9 GB Report
EGAF00000861590 bam 3.8 GB Report
EGAF00000861591 bam 3.5 GB Report
EGAF00000864336 bam 6.0 GB Report
EGAF00000864345 bam 8.7 GB Report
EGAF00000864353 bam 5.9 GB Report
EGAF00000864362 bam 6.1 GB Report
EGAF00000864366 bam 5.5 GB Report
EGAF00000864374 bam 5.2 GB Report
EGAF00000864380 bam 2.7 GB Report
EGAF00000864387 bam 5.3 GB Report
EGAF00000864394 bam 3.8 GB Report
EGAF00000864405 bam 5.2 GB Report
EGAF00000887883 bam 4.8 GB Report
EGAF00000887887 bam 6.3 GB Report
EGAF00000887891 bam 4.9 GB Report
EGAF00000887903 bam 4.4 GB Report
EGAF00000887904 bam 5.4 GB Report
EGAF00000887915 bam 3.7 GB Report
EGAF00000887918 bam 3.0 GB Report
EGAF00000887921 bam 3.5 GB Report
EGAF00000887933 bam 4.1 GB Report
EGAF00000887942 bam 4.3 GB Report
EGAF00000887950 bam 3.5 GB Report
EGAF00000887953 bam 5.0 GB Report
EGAF00000887957 bam 6.2 GB Report
EGAF00000887964 bam 6.0 GB Report
EGAF00000887975 bam 3.1 GB Report
EGAF00000887982 bam 3.0 GB Report
EGAF00000887997 bam 5.0 GB Report
EGAF00000888674 bam 8.3 GB Report
48 Files (226.3 GB)